DMD and Duchenne muscular dystrophy: Dystrophin restoration of 20% expression (Pelosi et al., 2015, Shimizu-Motohashi et al., 2019) is considered the point of efficacy for a DMD therapy (Mendell et al., 2012) and was found to increase by 32.8% in both the treatment groups (Fig. 1G,H) of the present study from baseline.